Genomic technology is a relatively new and disruptive technology in healthcare. Its successful implementation relies on whole-of-system change. Genomic medicine has the potential to transform how we deliver healthcare. It promises better patient outcomes and a more efficient health system through rapid diagnosis, early intervention, prevention and targeted therapy.
In the next five years, genomic data from an estimated 60 million patients globally is expected to be generated from health care. The volume and complexity of that data – and how it is accessed, shared and applied – are enormous. So too are the associated issues around genomic medicine such as data storage, ethics and privacy, nationally-consistent practices, patient access, economic impact and workforce capability.
The Australian Genomics Health Alliance (Australian Genomics) was launched in 2016 to address many of these challenges and to build the evidence to inform the integration of genomic medicine into mainstream healthcare.
We were established with a National Health and Medical Research Council grant in 2016 and now manage over $55M delivering genomic projects with additional funding from philanthropy and the Genomics Health Futures Mission.